pifithrin has been researched along with Muscular Atrophy in 1 studies
pifithrin: a tetrahydrobenzothiazol; inhibitor of P53 that protects mice from the side effects of cancer therapy; structure in first source
Muscular Atrophy: Derangement in size and number of muscle fibers occurring with aging, reduction in blood supply, or following immobilization, prolonged weightlessness, malnutrition, and particularly in denervation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsumoto, C | 1 |
| Sekine, H | 1 |
| Zhang, N | 1 |
| Mogami, S | 1 |
| Fujitsuka, N | 1 |
| Takeda, H | 1 |
1 other study available for pifithrin and Muscular Atrophy
| Article | Year |
|---|---|
Role of p53 in Cisplatin-Induced Myotube Atrophy.
Topics: Animals; Cisplatin; Muscle Fibers, Skeletal; Muscle, Skeletal; Muscular Atrophy; Quality of Life; RN | 2023 |